ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOANNE LANGTON MD

Endocrinology, Diabetes Metabolism

11,692

$1.52M

864
470 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 46%

$130
Average prescription price

Avg: $131

MATTHEW BEASEY MD

Endocrinology, Diabetes Metabolism

9,533

$1.09M

1113
602 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 46%

$115
Average prescription price

Avg: $131

MAHER GHAWJI M.D.

Endocrinology, Diabetes Metabolism

8,424

$1.03M

701
559 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 46%

$122
Average prescription price

Avg: $131

MUBASHIR MAHMOOD M.D.

Endocrinology, Diabetes Metabolism

8,335

$1.19M

585
250 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 46%

$143
Average prescription price

Avg: $131

DAVID ESCALANTE MD

Endocrinology, Diabetes Metabolism

8,166

$918K

535
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 46%

$112
Average prescription price

Avg: $131

ALDO ILARDE MD

Endocrinology, Diabetes Metabolism

7,670

$565K

522
375 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 46%

$74
Average prescription price

Avg: $131

RALPH GOODMAN M.D.

Endocrinology, Diabetes Metabolism

7,185

$847K

551
482 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 46%

$118
Average prescription price

Avg: $131

TERRI JERKINS M.D.

Endocrinology, Diabetes Metabolism

6,370

$695K

264
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 46%

$109
Average prescription price

Avg: $131

LISA MYERS M.D.

Endocrinology, Diabetes Metabolism

6,351

$869K

380
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 46%

$137
Average prescription price

Avg: $131

JOHN MCRAE MD

Endocrinology, Diabetes Metabolism

5,705

$830K

554
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 46%

$145
Average prescription price

Avg: $131

RABIH HIJAZI MD

Endocrinology, Diabetes Metabolism

5,386

$786K

403
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 46%

$146
Average prescription price

Avg: $131

CASEY PAGE M.D.

Endocrinology, Diabetes Metabolism

4,849

$612K

350
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 46%

$126
Average prescription price

Avg: $131

JAMES SULLIVAN M.D.

Endocrinology, Diabetes Metabolism

4,762

$271K

195
92 are 65+

11%
patients receiving schedule two controlled substances

Avg: 0%

32%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 46%

$57
Average prescription price

Avg: $131

LAKSHMI KRISHNAMURTHI MD

Endocrinology, Diabetes Metabolism

4,703

$431K

313
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 46%

$92
Average prescription price

Avg: $131

ANA CORNEA MD

Endocrinology, Diabetes Metabolism

4,271

$643K

596
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 46%

$151
Average prescription price

Avg: $131

ASMA KHAN M.D

Endocrinology, Diabetes Metabolism

4,227

$854K

437
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 46%

$202
Average prescription price

Avg: $131

JAMES GAUME MD

Endocrinology, Diabetes Metabolism

4,043

$678K

486
371 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 46%

$168
Average prescription price

Avg: $131

THOMAS HUGHES MD

Endocrinology, Diabetes Metabolism

3,961

$356K

253
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 46%

$90
Average prescription price

Avg: $131

JULIE HENDRIX M.D.

Endocrinology, Diabetes Metabolism

3,630

$412K

235
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 46%

$113
Average prescription price

Avg: $131

SABA KHAYAL MD

Endocrinology, Diabetes Metabolism

3,560

$566K

406
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 46%

$159
Average prescription price

Avg: $131

MICHAEL NANNENGA MD

Endocrinology, Diabetes Metabolism

3,514

$310K

574
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 46%

$88
Average prescription price

Avg: $131

JOHN CH NG MD

Endocrinology, Diabetes Metabolism

3,454

$386K

414
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 46%

$112
Average prescription price

Avg: $131

DAVID HUFFMAN MD

Endocrinology, Diabetes Metabolism

3,424

$667K

370
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 46%

$195
Average prescription price

Avg: $131

BEVERLY WILLIAMS-CLEAVES MD

Endocrinology, Diabetes Metabolism

3,113

$318K

204
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$102
Average prescription price

Avg: $131

THOMAS DOTY MD

Endocrinology, Diabetes Metabolism

3,093

$438K

342
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$142
Average prescription price

Avg: $131

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank